NXTC - NextCure, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
0
0
0
22,378
6,347
Operating Expense
75,909
75,909
70,765
63,603
43,829
Operating Income
-75,909
-75,909
-70,765
-41,225
-37,482
Other Income Expense
1,176
1,176
1,376
4,622
3,745
Pretax Income
-74,733
-74,733
-69,389
-36,603
-33,737
Net Income Common Stockholders
-74,733
-74,733
-69,389
-36,603
-33,737
Diluted NI Available to Com Stockholders
-74,733
-74,733
-69,389
-36,603
-33,737
Basic EPS
-
-2.69
-2.51
-1.33
-2.15
Diluted EPS
-
-2.69
-2.51
-1.33
-2.15
Basic Average Shares
-
27,744
27,616
27,532
15,695
Diluted Average Shares
-
27,744
27,616
27,532
15,695
Total Operating Income as Reported
-75,909
-75,909
-70,765
-41,225
-37,482
Total Expenses
75,909
75,909
70,765
63,603
43,829
Net Income from Continuing & Discontinued Operation
-74,733
-74,733
-69,389
-36,603
-33,737
Normalized Income
-74,733
-74,733
-69,389
-36,603
-33,737
EBIT
-75,909
-75,909
-70,765
-41,225
-37,482
EBITDA
-71,785
-
-
-
-
Reconciled Depreciation
4,124
4,124
7,196
3,413
2,688
Net Income from Continuing Operation Net Minority Interest
-74,733
-74,733
-69,389
-36,603
-33,737
Normalized EBITDA
-71,785
-75,909
-63,569
-41,225
-34,794
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0

Yahoo Finance Plus Essential access required.

Learn more